Veeva Systems (NYSE:VEEV) & Schrodinger (NASDAQ:SDGR) Head to Head Comparison

Schrodinger (NASDAQ:SDGRGet Free Report) and Veeva Systems (NYSE:VEEVGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.

Insider & Institutional Ownership

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 88.2% of Veeva Systems shares are owned by institutional investors. 21.0% of Schrodinger shares are owned by insiders. Comparatively, 10.3% of Veeva Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations for Schrodinger and Veeva Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schrodinger 1 4 4 0 2.33
Veeva Systems 1 7 17 0 2.64

Schrodinger presently has a consensus target price of $21.13, indicating a potential upside of 71.89%. Veeva Systems has a consensus target price of $283.70, indicating a potential upside of 52.11%. Given Schrodinger’s higher probable upside, analysts clearly believe Schrodinger is more favorable than Veeva Systems.

Profitability

This table compares Schrodinger and Veeva Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Schrodinger -40.37% -29.47% -14.69%
Veeva Systems 28.44% 14.11% 11.76%

Risk and Volatility

Schrodinger has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Veeva Systems has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

Earnings and Valuation

This table compares Schrodinger and Veeva Systems”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Schrodinger $255.87 million 3.55 -$103.26 million ($1.42) -8.65
Veeva Systems $3.20 billion 9.59 $908.91 million $5.41 34.47

Veeva Systems has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

Summary

Veeva Systems beats Schrodinger on 11 of the 14 factors compared between the two stocks.

About Schrodinger

(Get Free Report)

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

About Veeva Systems

(Get Free Report)

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.